Neuberger Berman Group
IART icon

Neuberger Berman Group’s Integra LifeSciences IART Stock Holding History

Neuberger Berman Group’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$19.9M Buy
2,115,255
+38,075
+2% +$418K 0.02% 662
2025
Q4 		$25.8M Buy
2,077,180
+541,996
+35% +$7.21M 0.02% 606
2025
Q3 		$22M Buy
1,535,184
+676,618
+79% +$9.27M 0.02% 650
2025
Q2 		$10.5M Sell
858,566
-78,696
-8% -$1.14M 0.01% 784
2025
Q1 		$20.6M Buy
937,262
+17,812
+2% +$419K 0.02% 619
2024
Q4 		$20.8M Buy
919,450
+43,870
+5% +$958K 0.02% 643
2024
Q3 		$15.9M Buy
875,580
+47,031
+6% +$1.09M 0.01% 705
2024
Q2 		$24.1M Buy
828,549
+183,977
+29% +$5.46M 0.02% 594
2024
Q1 		$22.8M Buy
644,572
+144,143
+29% +$5.77M 0.02% 616
2023
Q4 		$21.8M Buy
500,429
+55,610
+13% +$2.19M 0.02% 601
2023
Q3 		$17M Buy
444,819
+285,686
+180% +$12M 0.02% 628
2023
Q2 		$6.55M Buy
159,133
+155,087
+3,833% +$7.46M 0.01% 831
2023
Q1 		$232K Buy
4,046
+267
+7% +$15K ﹤0.01% 1676
2022
Q4 		$212K Buy
+3,779
New +$192K ﹤0.01% 1679
2020
Q2 		– Sell
-12,500
Closed -$558K – 1565
2020
Q1 		$558K Buy
+12,500
New +$656K ﹤0.01% 1220
2017
Q1 		– Sell
-457,688
Closed -$19.6M – 1609
2016
Q4 		$19.6M Sell
457,688
-3,460
-0.8% -$141K 0.03% 591
2016
Q3 		$19M Buy
461,148
+48,686
+12% +$2.04M 0.03% 608
2016
Q2 		$16.5M Sell
412,462
-7,726
-2% -$278K 0.02% 646
2016
Q1 		$14.2M Buy
420,188
+153,148
+57% +$4.77M 0.02% 680
2015
Q4 		$9.05M Buy
+267,040
New +$8.35M 0.01% 787

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Neuberger Berman Group's IART Position: Q1 2026 in Review

Neuberger Berman Group increased its Integra LifeSciences (IART) stake by 1.8% in Q1 2026, buying an estimated $418K and bringing the position to 2,115,255 shares worth $19.9M. The position accounts for 0.02% of the portfolio, ranked #662.

Neuberger Berman Group first reported a position in IART in Q4 2015 and has held it in 20 quarters since. The position peaked at $25.8M in Q4 2025. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.

  • Neuberger Berman Group held 2,115,255 shares of Integra LifeSciences worth $19.9M as of Q1 2026.
  • Neuberger Berman Group bought 38,075 Integra LifeSciences shares in Q1 2026, an estimated $418K.
  • Integra LifeSciences made up 0.02% of Neuberger Berman Group's portfolio in Q1 2026, its #662 holding.
  • Neuberger Berman Group first reported a position in Integra LifeSciences in Q4 2015 and has held it in 20 quarters since.
  • Neuberger Berman Group's Integra LifeSciences position peaked at $25.8M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.

Based on Neuberger Berman Group's 13F filing for Q1 2026, filed 14 May 2026.